{
    "code": 0,
    "data": [
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bd6c099-78fa-4f2d-ab71-e624e4616517.pdf",
            "news_date": "2026-02-07 18:19:58"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release and Presentation dated February 06 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=417b2d60-93cb-41ee-894e-0fb0d9135b08.pdf",
            "news_date": "2026-02-06 12:49:18"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For Quarter And Nine Months Ended December 31 2025",
            "news_body": "Un-audited Financial Results for quarter and nine months ended December 31 2025",
            "news_id": "698fa576-f2c3-4e4d-9785-ae595cefa15f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bdbc421-668d-46c2-98ea-e564221bea21.pdf",
            "news_date": "2026-02-06 12:44:08",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results For Quarter And Nine Months Ended December 31 2025",
            "news_body": "Un-audited Financial Results for quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bdbc421-668d-46c2-98ea-e564221bea21.pdf",
            "news_date": "2026-02-06 12:44:08"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Meeting Held On February 06 2026",
            "news_body": "Outcome of Board Meeting held on February 06 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab31d755-940e-45ae-86c5-35075c1a40ae.pdf",
            "news_date": "2026-02-06 12:39:37"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of  Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75a2f025-258c-4b4c-b48a-b9c10e78e1db.pdf",
            "news_date": "2026-02-02 21:38:47"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01ab7aa5-e989-4b79-9b08-a44204bf7ce4.pdf",
            "news_date": "2026-02-02 21:32:55"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company For The Quarter and Nine Months Ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82f9e2e0-2a0b-4240-8c5c-3fce7ae26608.pdf",
            "news_date": "2026-01-22 17:36:05"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under regulation 74(5) of SEBI(DP) Regulation 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a0fb9ee-321e-4bae-91a6-bccf42b91a3f.pdf",
            "news_date": "2026-01-06 19:13:59"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Report On Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares",
            "news_body": "Report on Special Window for Re-Lodgement of Transfer Requests of Physical Shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdbf1c01-20e8-47f8-9160-d38c6f852da1.pdf",
            "news_date": "2026-01-02 18:11:09"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Order Received From The Income Tax Department",
            "news_body": "Order received from the Income Tax Department",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ad3f592-5e88-4acc-956c-df731609409a.pdf",
            "news_date": "2025-12-31 12:53:02"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Initial Investment in Jubilant Pharmaceuticals INC. Canada",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5c2c907-0f04-42ea-863f-b54057bdfac1.pdf",
            "news_date": "2025-12-30 17:46:51"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding Trading Window Closure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59e9a73c-a5cf-403f-8e50-15f6729db4ee.pdf",
            "news_date": "2025-12-29 15:38:24"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Jubilant Generics Limited - Order Passed By The\r\nAssistant Commissioner Central GST Division Roorkee",
            "news_body": "Jubilant Generics Limited - Order passed by the Assistant Commissioner Central GST Division Roorkee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98e5162b-9b4e-46be-a6dc-fdc207c8a413.pdf",
            "news_date": "2025-12-27 12:13:37"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Receipt Of Adjudication Order_GST",
            "news_body": "Receipt of Adjudication Order by Deputy Commissioner of Commercial Taxes",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d34481a1-5f26-4c75-9b08-12490479321e.pdf",
            "news_date": "2025-12-05 16:46:36"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Report On Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares",
            "news_body": "Report on Special Window for Re-lodgement of Transfer Requests of Physical Shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6cb3c55a-8836-4cb8-b946-7e2ab126eef2.pdf",
            "news_date": "2025-12-02 17:24:13"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Mr. Daniel J. OConnor As CEO Of Jubilant Therapeutics Inc.",
            "news_body": "Appointment of Mr. Daniel J. O Connor as CEO of Jubilant Therapeutics Inc.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9dbf721e-3cb1-466e-b977-92063aad229e.pdf",
            "news_date": "2025-12-02 07:33:12"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Special window for re-lodgement and KYC Updation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d279bc9a-6d85-4635-81aa-089028f8ad97.pdf",
            "news_date": "2025-11-28 18:41:39"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Submission Of Communication Email Sent To Shareholders Whose Dividend(S) Remains Unpaid Pursuant To \"Saksham Niveshak - 100 Days Campaign\"",
            "news_body": "Submission of Communication Email sent to Shareholders whose Dividend(s) remains unpaid pursuant to \"Saksham Niveshak-100 Days Campaign\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eea6a16b-6c6a-425b-bbae-e8bcee224f1f.pdf",
            "news_date": "2025-11-08 23:25:01"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "USFDA Communication Montreal Canada",
            "news_body": "USFDA Communication Montreal Canada",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afe0b5ff-972d-47b0-8c84-552d39b9ca11.pdf",
            "news_date": "2025-11-04 20:10:16"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper publication - Unaudited Financial Results for quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b22bb49-818b-4059-92af-e3003a3b64de.pdf",
            "news_date": "2025-11-01 20:50:14"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release along with Earning presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77615ab8-04a3-4a72-9b9e-3d3fe8271bc1.pdf",
            "news_date": "2025-10-31 13:11:22"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Approval For Grant Of Stock Options/Rsus",
            "news_body": "Approval of Grant of Stock Options/RSUs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3905197f-902a-427e-bbf9-c990c85470cf.pdf",
            "news_date": "2025-10-31 13:07:58"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Un-audited Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "648a7e35-c7cf-46d3-a3f2-b823a395e0b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c54bdc76-b062-4253-8a6d-80c4f1d41d3d.pdf",
            "news_date": "2025-10-31 13:05:29",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Un-audited Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c54bdc76-b062-4253-8a6d-80c4f1d41d3d.pdf",
            "news_date": "2025-10-31 13:05:29"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Meeting Held On October 31 2025",
            "news_body": "Outcome of the Board Meeting held on October 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=901ff233-3186-452b-94c4-20bb6fea3e39.pdf",
            "news_date": "2025-10-31 13:01:12"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Letter To Shareholders Whose KYC Is Not Updated",
            "news_body": "Letter to shareholders whose KYC is not updated",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6c1112f-1bc1-42a5-8956-8586547ae2ef.pdf",
            "news_date": "2025-10-27 17:49:15"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f8ad1cf-b041-4631-802d-c13764948771.pdf",
            "news_date": "2025-10-14 19:10:54"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Press Release Pertaining To The Launch Of New High-Speed Isolator Based Line At Its Spokane Manufacturing Facility In The US By Jubilant Hollisterstier LLC USA A Wholly-Owned Subsidiary Of The Company",
            "news_body": "Intimation under Reg 30 - Launch of New High Speed Isolator base line at its Spokane Manufacturing Facility in US by Jubilant HollisterStier LLC",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25606cc1-a27e-4a25-bb83-80c28440929d.pdf",
            "news_date": "2025-10-10 08:03:00"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Submission Of Communication Email Sent To Shareholders Whose Dividend(S) Remains\r\nUnpaid Pursuant To \"Saksham Niveshak - 100 Days Campaign\"",
            "news_body": "Submission of communication email sent to shareholders whose dividend(s) remains  unpaid pursuant to \"Saksham Niveshak - 100 Days Campaign\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8005746e-60f6-4ebf-86e4-1361d27f8168.pdf",
            "news_date": "2025-10-08 20:20:38"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance certificate under Regulation 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89369187-761b-4dd5-9e89-51428d2ae7f6.pdf",
            "news_date": "2025-10-07 16:55:05"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa82eb47-dd95-4c57-9b82-68dcd36ca050.pdf",
            "news_date": "2025-10-01 23:35:41"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Allotment Of Optionally Convertible Redeemable Non-Cumulative Preference Shares (OCRPS) By Jubilant Biosys Limited A Wholly Owned Subsidiary Company",
            "news_body": "Allotment of Optionally Convertible Redeemable Non-Cumulative Preference Shares(OCRPS) by Jubilant Biosys Limited a wholly owned subsidiary Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87a08ecd-3b86-4fd4-9957-89ae8150f367.pdf",
            "news_date": "2025-10-01 13:29:00"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81f38060-4745-48a8-9897-ad263dc8f56c.pdf",
            "news_date": "2025-09-30 18:35:31"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ae94141-5815-4066-99a1-2807c79ca87b.pdf",
            "news_date": "2025-09-30 18:34:38"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of CFO of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bde6d75e-d9b0-4c4a-8116-cd5438f2430e.pdf",
            "news_date": "2025-09-23 11:40:28"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On September 23 2025",
            "news_body": "Outcome of Board Meeting held on September 23 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5cc65cf-1aef-480b-96f6-5db956694f03.pdf",
            "news_date": "2025-09-23 11:38:35"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 - Jubilant Pharmova Announces Completion Of Pharmacovigilance Inspection\r\nBy The USFDA With No Observations",
            "news_body": "Disclosure under Regulation 30 - Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Obervations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=641fba91-1b40-4315-bcb8-c7f559005333.pdf",
            "news_date": "2025-09-20 20:35:24"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Reminder Email Sent To Shareholders Intimating About The 100 Days Campaign",
            "news_body": "Reminder email sent to shareholders intimating about the 100 days campaign",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4954abb0-eae4-4ffc-ba4f-92acefa81d9f.pdf",
            "news_date": "2025-09-12 20:02:12"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of Orders Passed By The Additional Commissioner Central Tax (Appeals) Mysuru",
            "news_body": "Disclosure under Regulation 30 - Receipt of Orders passed by the Additional Commissioner Central Tax (Appeals) Mysuru",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2167f4d-7f79-44be-bc6b-1ddd53cff239.pdf",
            "news_date": "2025-09-02 23:42:02"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 - Completion Of Sale And Transfer Of API Business",
            "news_body": "Disclosure under Regulation 30 - Completion of Sale and Transfer of API Business",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=724dbf97-b402-4f28-8840-21a4d343d69c.pdf",
            "news_date": "2025-09-01 23:42:53"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Resignation of Senior Management Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d9f776d-d898-4afb-bfbe-a3909196d266.pdf",
            "news_date": "2025-09-01 13:54:30"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
            "news_body": "Resignation of Dr. Ramakrishnan Arul Whole-Time Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acb00742-2bef-4a20-8fa7-34ae6d3c2cfa.pdf",
            "news_date": "2025-09-01 13:50:36"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Scrutinizers Report dated August 29 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2868e2ac-7d1d-4b02-a531-50bdabd30218.pdf",
            "news_date": "2025-08-29 21:46:36"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings and Voting results of 47th AGM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a9e8640-0edd-4201-a495-ebd0aa2067bb.pdf",
            "news_date": "2025-08-29 21:43:30"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 18 2025 for SPB Trustee Company Pvt Ltd and SS Trustee Company Pvt Ltd (Jointly acting as Trustee on behalf of Shyam Sunder Bhartia Family Trust) & HSB Trustee Company Pvt Ltd and HS Trustee Company Pvt Ltd (Jointly acting as Trustee on behalf of Hari Shanker Bhartia Family Trust)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=A1085E9E_37FE_45BB_A3A0_04A651572A8F_110656.pdf",
            "news_date": "2025-08-19 11:07:02"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Investor / Analyst meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97d45f6f-62ae-41c9-82bd-ad9b8a50f634.pdf",
            "news_date": "2025-08-07 23:03:59"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Notice to Shareholders - 100 days Campaign - Saksham Niveshak",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d77ba08f-8c1f-42ab-9bb9-0952e4731350.pdf",
            "news_date": "2025-08-07 22:58:19"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Advertisement titled Notice of 47th AGM E-voting Record Date and Final Dividend Information.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed293dd5-3def-42ae-92be-296d007a05bf.pdf",
            "news_date": "2025-08-06 16:57:05"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding A Letter Dispatched To The Shareholders  For Annual Report Of The Company For FY 2024-25",
            "news_body": "Intimation regarding a letter dispatched to the Shareholders  for Annual Report of the Company for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d666c658-bf2e-4046-92be-b9ad73080965.pdf",
            "news_date": "2025-08-05 23:39:09"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report of the Company for the financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=519f6679-b13e-4ebc-8902-43ae69dd36a2.pdf",
            "news_date": "2025-08-05 23:21:11"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 47Th Annual General Meeting Alongwith The Annual Report For The Financial Year 2024-25",
            "news_body": "Notice of 47th Annual General Meeting alongwith the Annual Report for the financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=349bd252-9e0c-492a-a0ea-53559dc03620.pdf",
            "news_date": "2025-08-05 22:48:43"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report for the FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57abf49c-f5fa-4432-a09c-e137ee87b952.pdf",
            "news_date": "2025-08-05 20:00:38"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "E-Mail Communication To Shareholders Intimating About Deduction Of Tax At Source (TDS) On Final Dividend For FY\r\n2024-25",
            "news_body": "Email communication to shareholders intimating about deduction of tax at source (TDS) on Final Dividend for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0d68c0d-86fa-4c80-b5de-7f8c45d17cd3.pdf",
            "news_date": "2025-08-04 22:11:36"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper publication - Notice of transfer of equity shares / unclaimed dividend to IEPF Authority",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e8c67fc-506f-4a6d-a544-e44456f1838e.pdf",
            "news_date": "2025-08-02 19:34:47"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Publication - 47th Annual General Meeting of the Company to be held on Friday August 29 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8aad4549-776d-4210-b712-f3a8b768e300.pdf",
            "news_date": "2025-08-02 19:29:41"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Completion Of Pre-Approval Inspection (PAI) By USFDA Of Solid Dosage Manufacturing Facility At Roorkee India",
            "news_body": "Completion of pre-approval inspection (PAI) by USFDA of Solid dosage manufacturing facility at Roorkee India",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af9d9e9b-e3b6-4428-b246-ee53b5027438.pdf",
            "news_date": "2025-08-02 01:08:49"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Submission Of Communication Sent To Shareholders Relating To Notice Of Transfer Of Equity Shares / Dividend To Investor Education And Protection Fund Authority",
            "news_body": "Submission of communication sent to shareholders relating to notice of transfer of equity shares / dividend to Investor Education and Protection Fund Authority",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6141914-52b6-42ee-a7ca-b26c4997fb8a.pdf",
            "news_date": "2025-08-01 23:26:17"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of copies of Newspaper advertisement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c14750ee-d359-47a3-9fc5-7ca47ef05339.pdf",
            "news_date": "2025-08-01 23:19:36"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Investors / Analysts meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a093e6af-a90d-484d-b30d-37302a453466.pdf",
            "news_date": "2025-07-31 23:25:14"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of copies of published unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18890869-50d5-4a4d-9023-436153e00693.pdf",
            "news_date": "2025-07-30 16:42:58"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Resignation of Chief Financial Officer and Whole Time Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7629b114-701b-4383-9d6a-17b5bc7b510c.pdf",
            "news_date": "2025-07-29 14:18:48"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Chief Financial Officer (CFO)",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)",
            "news_body": "Resignation of Chief Financial Officer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=375a3736-714d-437c-9e99-a553f3c61513.pdf",
            "news_date": "2025-07-29 14:15:29"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release along with Earnings Presentation for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33cbcc25-39e8-416f-94d1-e21b941fa817.pdf",
            "news_date": "2025-07-29 13:59:40"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Grant Of Stock Options",
            "news_body": "Grant of Stock Options",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=182e9c35-1e93-4c47-9425-fa7159e1db8a.pdf",
            "news_date": "2025-07-29 13:40:47"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Re-appointment of Internal Auditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef7a868d-d7d1-472a-a24a-24077f1a74f8.pdf",
            "news_date": "2025-07-29 13:38:35"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Results For The Quarter Ended June 30 2025",
            "news_body": "Unaudited results for the quarter ended June 30 2025",
            "news_id": "b16a0125-7883-4955-8600-dd5bc05b8232",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dde98ab-c362-4633-b127-e34d36eade54.pdf",
            "news_date": "2025-07-29 13:35:00",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Results For The Quarter Ended June 30 2025",
            "news_body": "Unaudited results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dde98ab-c362-4633-b127-e34d36eade54.pdf",
            "news_date": "2025-07-29 13:35:00"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Approval Of Unaudited Financial Results",
            "news_body": "Approval of unaudited financial results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8efecc0-8d4b-45c3-83ef-ccc7e10521fa.pdf",
            "news_date": "2025-07-29 13:31:54"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Outcome of Postal Ballot - Voting Results and Scrutinizers Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=372ab719-e1aa-4155-b0e4-19117b7991a0.pdf",
            "news_date": "2025-07-24 22:33:40"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2025",
            "news_body": "Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e15f1363-0093-4e55-9525-bdd6a871f5b4.pdf",
            "news_date": "2025-07-23 11:52:27"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "Disclosure under Regulation 30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c814e841-18ff-437d-9641-fcdc4cfeb441.pdf",
            "news_date": "2025-07-22 21:49:24"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d8919eb-0398-4c35-a2ba-94066d6f0eab.pdf",
            "news_date": "2025-07-04 18:07:46"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding Trading Window Closure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=891448f2-5a03-486c-9bbe-bfaf7af04447.pdf",
            "news_date": "2025-06-26 18:12:33"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Newspaper Advertisement of Postal ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21b8f9b4-b776-4e34-bf24-7ff0b5252ae2.pdf",
            "news_date": "2025-06-25 23:52:28"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Disclosure under Regulation 30 - Notice of Postal Ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16bbf937-6e9a-497c-965a-421fc6e815b3.pdf",
            "news_date": "2025-06-24 21:18:23"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Investors/ Analysts Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12f1e37d-dede-439c-9551-d568fd5dbf40.pdf",
            "news_date": "2025-06-16 17:19:21"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for SPB Trustee Company Pvt Ltd & Others",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5093FA55_FEF3_4163_AF88_19C08D414288_130105.pdf",
            "news_date": "2025-06-16 13:01:07"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting - Sale and Transfer of API Business of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ec7d1a6-901b-4172-bb0c-80f581c0aad5.pdf",
            "news_date": "2025-06-12 15:51:39"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Restructuring",
            "caption": "Announcement under Regulation 30 (LODR)-Restructuring",
            "news_body": "Disclosure under Regulation 30 - Sale and Transfer of API Business of the Company on Slump Sale basis to Jubilant Biosys Limited a wholly owned subsidiary company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4e6ed26-2e4f-49c9-94dc-e9b856e354c7.pdf",
            "news_date": "2025-06-12 15:40:56"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 - Receipt Of Rectification Order From The Income Tax Department",
            "news_body": "Intimation under Regulation 30 - Receipt of rectification order from the Income tax department",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4866e668-afb1-4413-b207-66646e2a928c.pdf",
            "news_date": "2025-06-11 11:48:56"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for East Bridge Capital Master Fund I Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=731A5DA4_1E58_447F_9F29_BB2081612545_143605.pdf",
            "news_date": "2025-06-04 14:36:08"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Compliance Report for the financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c13bef89-1bbc-49ba-baa2-9be6193b106a.pdf",
            "news_date": "2025-05-29 19:14:00"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith copies of Newspaper advertisement pertaining to financial results of the Company for the quarter and financial year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb0ce5a9-75ae-4f26-8efc-4bcf3b73f9ab.pdf",
            "news_date": "2025-05-18 17:53:43"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "The Company has informed the Exchange regarding a Press Release alongwith Earnings Presentation for the quarter and financial year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=029d9e32-c37f-4e04-af41-5d4eff6fd583.pdf",
            "news_date": "2025-05-16 13:53:25"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "The Company Has Informed The Exchange That Record Date For The Purpose Of Dividend Is July 25 2025.",
            "news_body": "The Company has informed the Exchange that Record Date for the purpose of Dividend is July 25 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=477ee5cb-72ec-4e76-8453-108e3cc6d4de.pdf",
            "news_date": "2025-05-16 13:35:37"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Secretarial Auditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=581b2cf9-8815-48ac-a222-ba2f91fe1422.pdf",
            "news_date": "2025-05-16 13:32:33"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "The Board at its meeting held on May 16 2025 has recommended the final dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66db13ac-376b-40d1-9619-81512b5b7a65.pdf",
            "news_date": "2025-05-16 13:29:45"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Results For The Quarter And Financial Year Ended March 31 2025",
            "news_body": "Audited Financial results for the quarter and financial year ended March 31 2025",
            "news_id": "2023a534-c6b0-43cc-bd7e-8639dd5a9a13",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94172736-4639-436f-a19c-8c3a94055f96.pdf",
            "news_date": "2025-05-16 13:28:09",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Results For The Quarter And Financial Year Ended March 31 2025",
            "news_body": "Audited Financial results for the quarter and financial year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94172736-4639-436f-a19c-8c3a94055f96.pdf",
            "news_date": "2025-05-16 13:28:09"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 16 2025",
            "news_body": "Outcome of Board Meeting held on May 16 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f0ab3bc-5584-465b-a673-68c03b7b8e1d.pdf",
            "news_date": "2025-05-16 13:21:54"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Announcement under Regulation 30 - Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e90467b2-8088-4402-80a4-af361b130ee4.pdf",
            "news_date": "2025-05-06 20:23:52"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for 1. The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025.\r\n2. Recommendation Of Final Dividend If Any For The Financial Year Ended March 31 2025.",
            "news_body": "Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 inter alia to consider and approve 1. The audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025.\r\n\r\n2. Recommendation of Final Dividend if any for the Financial Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f19ade8-4e46-40e2-bb53-e9ea128c2387.pdf",
            "news_date": "2025-04-30 18:41:55"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Material Development About The Disclosure Made On February 25 2025",
            "news_body": "Update on material development about the disclosure made on February 25 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50c2e635-24e5-4198-b26c-5d50246cf18e.pdf",
            "news_date": "2025-04-20 15:13:23"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliances - Certificate under Regulation 74(5) of the SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebbefc54-c9ed-42bc-a180-b1d96a56c213.pdf",
            "news_date": "2025-04-10 15:46:19"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Amended And Restated Deed Of Private Trust Dated March 25 2025",
            "news_body": "Amended and Restated Deed of Private Trust dated March 25 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=273fcde4-f7c0-4335-8491-762761efd992.pdf",
            "news_date": "2025-03-25 20:28:19"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a21c4008-ae96-4ea0-936b-af9587db5ba6.pdf",
            "news_date": "2025-03-24 17:15:12"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Jubilant Biosys Innovative Research Services Pte Limited Singapore Has Executed Shareholders Agreement And Other Transition Agreements With Pie",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Jubilant Biosys Innovative Research Services Pte Limited Sinagpore has executed Shareholders Agreement and other transition agreements with Pierre Fabre SA.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad355e06-664a-4c16-b3bb-61bb5a6fcc27.pdf",
            "news_date": "2025-03-20 11:35:25"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 - USFDA Report For Jubilant Cadista Pharmaceuticals Inc. USA",
            "news_body": "Announcement under Regulation 30 - USFDA Report for Jubilant Cadista Pharmaceuticals INC. USA",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2696121-0fea-4281-8918-0f183f0d2d77.pdf",
            "news_date": "2025-03-12 18:37:50"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "GENERAL",
            "caption": "Rumour verification - Regulation 30(11)",
            "news_body": "Intimation under Regulation 30(11)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6cf87ff3-fffc-4fc4-be65-11031b943fb2.pdf",
            "news_date": "2025-02-25 12:40:11"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Investors / Analysts Meeting",
            "news_body": "Audio Recording of Investors Meet",
            "news_id": "5ec68d41-239f-4cf7-9c45-152cb6987ce1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8492a875-a254-45c1-8dbf-97bb22cc4ebc.pdf",
            "news_date": "2025-02-24 23:55:54",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Audio Recording Of Investors / Analysts Meeting",
            "news_body": "Audio Recording of Investors Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8492a875-a254-45c1-8dbf-97bb22cc4ebc.pdf",
            "news_date": "2025-02-24 23:55:54"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Presentation For Investor And Analyst Meet",
            "news_body": "Presentation for Investor and Analyst Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8649ba56-5ca6-4381-8428-bb22514f7806.pdf",
            "news_date": "2025-02-24 16:50:13"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Investors/ Analysts Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78dae6ce-183a-421f-9b9f-ae0b93cffea3.pdf",
            "news_date": "2025-02-05 17:10:04"
        },
        {
            "co_code": 592,
            "bse_code": 530019,
            "isin": "INE700A01033",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11195803-236d-4c42-9cdf-4d45a9d36039.pdf",
            "news_date": "2025-02-01 23:21:21"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Results For The Quarter Ended December 31 2024",
            "news_body": "Unaudited Results for the quarter ended December 31 2024",
            "news_id": "266ae6c6-1fe7-43f0-87ef-bb4b9d3b3c6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d6a4e2f-6c02-48a1-9492-dabeb981a51c.pdf",
            "news_date": "2025-01-31 13:05:26",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited Financial Results For Quarter And Half Year Ended September 30, 2024",
            "news_body": "Approval of Unaudted Financial Results for the quarter and half year ended September 30, 2024",
            "news_id": "7eb50faf-338c-4dd3-bc8c-9f752a078ebc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=349bf8a8-cce9-4870-8269-d95e5b6ae20c.pdf",
            "news_date": "2024-10-25 12:26:18",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For June 30, 2024",
            "news_body": "Unaudited Financial Results for June 30, 2024",
            "news_id": "5d0508a2-d6dd-4deb-a7ca-8e3eb4da6367",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4c50068-6906-4d8f-ad3a-e2b56af0ee83.pdf",
            "news_date": "2024-07-19 14:08:10",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For March 31, 2024",
            "news_body": "Audited Financial Results for March 31, 2024",
            "news_id": "1302be86-bc80-4b6e-8b8d-23aeacccdb36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6c39d01-03ae-487e-937d-12457fd8e683.pdf",
            "news_date": "2024-05-29 14:56:42",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Q3 FY 2024 Alongwith Limited Review Report",
            "news_body": "Unaudited Financial Results Q3 FY 2024 alongwith Limited Review Report",
            "news_id": "35871921-1c5d-4320-8a5e-21b9cd57cea2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64f6bb03-ad37-4374-a35c-aacc51461a7e.pdf",
            "news_date": "2024-02-02 14:24:32",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2023 Alongwith Limited Review Report For The Said Period.",
            "news_body": "Unaudited standalone & Consolidated financial Results for Q2 FY 2024",
            "news_id": "791c1c0a-b354-4623-a784-6b8e46fb832b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54aee475-ea9d-48bc-b42c-216742b4fdaf.pdf",
            "news_date": "2023-10-27 14:28:41",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023",
            "news_id": "1d8571ca-8e8f-4447-b963-a4db48514b0a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06ffcf78-8cd7-4eaa-ac72-4aba85b670df.pdf",
            "news_date": "2023-07-19 14:03:33",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Results For The Quarter And Year Ended March 2023",
            "news_body": "Audited Results for the quarter and year ended March 2023",
            "news_id": "5ea2069c-d8d4-4c38-bee2-082c4ebcc2d3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b93f1e1-3d39-4d86-aa8d-0c5bd53e1569.pdf",
            "news_date": "2023-05-29 15:45:58",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings conference call for the quarter and nine months ended December 31, 2022",
            "news_id": "fcd531b2-96ec-4f18-b58a-f1ff1558bea2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=016b00cc-23e6-4946-ba9c-6e3ddbd9307c.pdf",
            "news_date": "2023-02-09 12:20:11",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Link of Audio recording of investors conference call",
            "news_id": "3228bd3e-8ba6-4732-934f-96054f3aa842",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=294a6d26-e84f-4078-b805-3e676432b857.pdf",
            "news_date": "2023-02-03 21:29:54",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova - Q3 FY 2023 Results",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that Board of Directors of Jubilant Pharmova Ltd at its meeting held today i.e. Friday, February 03, 2023 considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2022. <BR> <BR> Copy of the unaudited financials results for the quarter ended December 31, 2022 alongwith Limited Review Reports issued by the Statutory Auditors on the Unaudited Financial Results (Standalone and Consolidated) for the said period and Press Release/Presentation on aforesaid financials is enclosed herewith.<BR> <BR> The Board Meeting commenced at 11:15 a.m. and concluded at 12.50 p.m. All the above mentioned documents will be simultaneously posted on the Company''s website at www.jubilantpharmova.com. You are requested to take note of the same.<BR>",
            "news_id": "268d69f2-c452-4100-a968-b0edca5d12dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10e83a8d-2c34-43f1-9f24-f73f96d86671.pdf",
            "news_date": "2023-02-03 13:03:36",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Q2FY23 RPT Transactions",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of the Related Party Transactions in the prescribed format for half year ended September 30, 2022.",
            "news_id": "7fc105ef-6b90-4fc0-9364-a5efb54bbe9e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d09bedc-ab5a-456d-a1d8-b2a3c76458ee.pdf",
            "news_date": "2022-11-04 18:41:31",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Link of audio recording",
            "news_id": "b1fcb91f-b219-404d-9d90-3194c814648e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f7210d1-9888-4194-9b37-9da6c2cb0e85.pdf",
            "news_date": "2022-10-22 14:57:22",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova Financial Results Q2 FY 2023",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2022 have been approved by the Board of Directors of the Company at its meeting held today at 11:45 a.m. and concluded at 1.30 p.m. <BR> <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022;<BR> <BR> 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said period; and<BR> <BR> 3. Copies of the Press Release and Presentation.<BR> <BR> We request you to take the same on record.<BR>",
            "news_id": "9808f845-c3fa-4169-bf99-4f40c6cb5495",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bfc1fb1-6dc9-44e4-a5f5-df035c01f726.pdf",
            "news_date": "2022-10-21 13:44:56",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the transcript of Analyst and Investor Conference Call for Unaudited financial results for the quarter ended June 30, 2022 conducted after the meeting of Board of Directors held on Tuesday, August 2, 2022.This is for your information and records.",
            "news_id": "49ab77f8-b7df-4ece-9857-9c6139f736bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0757cee2-24f0-46c9-8e00-5c5e7bdbfbe3.pdf",
            "news_date": "2022-08-08 19:48:23",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "we wish to inform that audio recording of Analyst and Investor Conference Call for Unaudited financial results for the quarter ended June 30, 2022 held on Tuesday, August 2, 2022, has been uploaded on the Company''s website and same is given in the attached letter.",
            "news_id": "95f9b3a6-1fee-48a8-a00a-048bfc7056ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51eae07f-e035-48d9-8fa3-668183ef20fc.pdf",
            "news_date": "2022-08-02 22:02:03",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova - Results Q1 FY 23",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2022 were approved by the Board of Directors of the Company at its meeting held today at 11:15 a.m. and concluded at 12.45 p.m.<BR> <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022;<BR> 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and<BR> 3. Copies of the Press Release and Presentation.<BR>",
            "news_id": "079d48b3-1ee4-4226-8e46-7064430e49b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=682adfff-03fd-4061-94b1-17a110ece948.pdf",
            "news_date": "2022-08-02 12:58:32",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Details Of Related Party Transactions For HYE March'' 2022",
            "news_body": "Details of Related Party Transactions for HYE March'' 2022",
            "news_id": "f09baa17-3e20-4f87-8b36-b0b413f00701",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8bfbf02-cad6-4204-8652-7e5cd02a7a61.pdf",
            "news_date": "2022-06-10 18:37:45",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the earnings conference call for the quarter and year ended March 31, 2022",
            "news_id": "971c949a-bd8c-4e86-81a7-b45ce876f217",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=478e6514-da3f-4034-8021-636441ae5227.pdf",
            "news_date": "2022-06-02 16:27:05",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that audio recording of Analyst and Investor Conference Call for Audited financial results for the quarter and financial year ended March 31, 2022 held on Friday, May 27, 2022, has been uploaded on the Company''s website. The link to access the audio call recording is:https://www.jubilantpharmova.com/investors/financials/quarterly-resultsThis is for your information and records.",
            "news_id": "26ce111e-9ca6-44ca-a99a-be851def7ddd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ad98d7d-e15c-4e03-a9be-9ef39475a442.pdf",
            "news_date": "2022-05-28 11:17:50",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova - FY22 Results",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2022 were approved by the Board of Directors of the Company at its meeting held today at 1:15 p.m. and concluded at 4.15 p.m. <BR> <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2022;<BR> <BR> 2. Audit Reports for Standalone and Consolidated Financial Results; <BR> <BR> 3. Copies of the Press Release and Presentation.<BR> <BR> We declare that the Reports of Auditors are with unmodified opinion with respect to the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2022.",
            "news_id": "837d261c-ab84-4c95-a535-24184f477d6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e966be1d-991d-4636-ba71-865f15b155eb.pdf",
            "news_date": "2022-05-27 16:30:33",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova - Q3 FY 2022 Results",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2021 were approved by the Board of Directors of the Company at its meeting held today at 12.15 p.m. and concluded at 3.20 p.m. <BR>  <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2021;<BR> 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and<BR> 3. Copies of the Press Release and Presentation.<BR> <BR> We request you to take the same on records.<BR>",
            "news_id": "6d6a0c84-418a-4ef4-90b8-b6826c990645",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e85c44-4491-4697-857b-6b7de70434c6.pdf",
            "news_date": "2022-02-04 15:32:46",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova Q2 FY 2022",
            "news_body": "Dear Sirs, <BR> In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2021 have been approved by the Board of Directors of the Company at its meeting held today at 1:15 p.m. and concluded at 2.45 p.m. <BR> <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2021;<BR> <BR> 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said period; and<BR> <BR> 3. Copies of the Press Release and Presentation.",
            "news_id": "2ae23787-940a-4a75-9cda-ec627a649944",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec9d4e84-98e9-467c-9fcf-4628dfaec819.pdf",
            "news_date": "2021-10-22 14:57:16",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter Ended June 30, 2021",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2021 were approved by the Board of Directors of the Company at its meeting held today at 1:30 p.m. and concluded at 4.00 p.m.<BR>  <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2021;<BR> <BR> 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and<BR> <BR> 3. Copies of the Press Release and Presentation.<BR> <BR> We request you to take the same on records.<BR>",
            "news_id": "91626ad9-85a0-4f2d-890d-6030e142fd45",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33fbd423-fb7c-4eb5-ac64-0646b302b82d.pdf",
            "news_date": "2021-07-23 16:08:46",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of<BR> Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the Financial Year ended March 31, 2021.",
            "news_id": "6c45f2be-8d18-499f-96d1-a21f61a93a9a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22f76afe-c31d-4282-8a53-5e0158796fb3.pdf",
            "news_date": "2021-06-29 11:13:51",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of our letter dated June 10, 2021, we enclose presentation to be made at Investor and Analyst Meet on June 18, 2021.",
            "news_id": "6e34fb4b-a795-4a5f-88ae-5bd206603ba6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=885976f9-369e-4db2-a565-7df37d10f00b.pdf",
            "news_date": "2021-06-18 13:33:30",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Year Ended March 31, 2021",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2021 were approved by the Board of Directors of the Company at its meeting held today at 1:35 p.m. and concluded at 4.20 p.m. <BR> <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2021;<BR> <BR> 2. Audit Reports for Standalone and Consolidated Financial Results; <BR> <BR> 3. Copies of the Press Release and Presentation.<BR> <BR> We declare that the Reports of Auditors are with unmodified opinion with respect to the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2021.<BR> <BR>",
            "news_id": "4fcb3b30-8096-40e5-bf87-a3ffd20e03fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71f935e5-a644-4bf3-91da-ea249a6f1ebd.pdf",
            "news_date": "2021-06-04 16:31:56",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}